Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO)

CUSIP: 03835L405

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
3,581,500
Total 13F shares
19,629
Share change
-28,862
Total reported value
$22,769
Price per share
$1.16
Number of holders
8
Value change
-$168,977
Number of buys
5
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 03835L405?
CUSIP 03835L405 identifies APVO - Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO) as of Q1 2025

As of 31 Mar 2025, Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,629 shares. The largest 8 holders included GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), CLEAR STREET LLC, BANK OF AMERICA CORP /DE/, SBI Securities Co., Ltd., BlackRock, Inc., MORGAN STANLEY, and OSAIC HOLDINGS, INC.. This page lists 8 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.